POLICY LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Changes in Present Value of Expected Net Premiums and Expected Future Policy Benefits

The following tables present the changes in the present value of expected future net premiums and the present value of expected future policy benefits by reporting segment and disaggregated by product type. The present value of expected future net premiums and the present value of expected future policy benefits are presented gross of internal and external ceded reinsurance.


	March 31, 2026
	Aflac Japan								Aflac U.S.
(In millions)	Cancer		Medical and Other Health		Life Insurance		Other		Accident		Disability		Critical Care		Hospital Indemnity		Dental/ Vision		Life Insurance		Other
Present value of expected future net premiums:
Balance at December 31, 2025	$	12,207	$	10,349	$	4,547	$	725	$	2,525	$	1,685	$	3,945	$	1,171	$	202	$	1,021	$	1,968
Beginning balance at original discount rate	13,201		11,511		4,772		800		2,637		1,726		4,242		1,231		208		1,051		1,835
Effect of changes in cash flow assumptions	0		0		0		0		0		0		0		0		0		0		0
Effect of actual variances from expected experience	(147)		(84)		(14)		(3)		(23)		(2)		(29)		(14)		(2)		(9)		(16)
Adjusted beginning of period balance	13,054		11,427		4,758		797		2,614		1,724		4,213		1,217		206		1,042		1,819
Issuances	216		14		83		1		111		109		204		90		13		94		469
Interest accrual	86		68		26		4		27		18		44		12		2		11		27
Net premiums collected (1)	(314)		(247)		(179)		(22)		(119)		(100)		(143)		(61)		(10)		(44)		(50)
Foreign currency translation	(272)		(235)		(98)		(17)		0		0		0		0		0		0		0
Other	0		0		0		0		0		0		0		0		0		0		0
Ending balance at original discount rate	12,770		11,027		4,590		763		2,633		1,751		4,318		1,258		211		1,103		2,265
Effect of changes in discount rate assumptions	(1,252)		(1,402)		(303)		(86)		(148)		(62)		(360)		(75)		(9)		(42)		65
Balance at March 31, 2026	$	11,518	$	9,625	$	4,287	$	677	$	2,485	$	1,689	$	3,958	$	1,183	$	202	$	1,061	$	2,330
Present value of expected future policy benefits:
Balance at December 31, 2025	$	34,987	$	17,692	$	20,894	$	3,671	$	3,184	$	2,336	$	10,845	$	1,955	$	438	$	2,076	$	2,444
Beginning balance at original discount rate	36,438		21,979		25,716		4,758		3,348		2,401		11,812		2,071		458		2,288		2,304
Effect of changes in cash flow assumptions	0		0		0		0		0		0		0		0		0		0		0
Effect of actual variances from expected experience	(168)		(101)		(18)		(8)		(36)		(5)		(41)		(19)		(1)		(13)		(14)
Adjusted beginning of period balance	36,270		21,878		25,698		4,750		3,312		2,396		11,771		2,052		457		2,275		2,290
Issuances	221		15		85		2		116		115		215		95		14		100		474
Interest accrual	303		134		134		22		34		25		127		22		5		23		33
Benefit payments	(638)		(237)		(665)		(60)		(126)		(118)		(247)		(77)		(15)		(29)		(56)
Foreign currency translation	(750)		(452)		(525)		(98)		0		0		0		0		0		0		0
Other	0		0		0		0		0		0		0		0		0		0		0
Ending balance at original discount rate	35,406		21,338		24,727		4,616		3,336		2,418		11,866		2,092		461		2,369		2,741
Effect of changes in discount rate assumptions	(2,470)		(4,862)		(5,333)		(1,181)		(211)		(96)		(1,176)		(146)		(27)		(251)		63
Balance at March 31, 2026	32,936		16,476		19,394		3,435		3,125		2,322		10,690		1,946		434		2,118		2,804
Net liability for future policy benefits	21,418		6,851		15,107		2,758		640		633		6,732		763		232		1,057		474
Less: reinsurance recoverable	4,142		994		316		0		0		0		0		0		0		26		20
Net liability for future policy benefits after reinsurance recoverable	$	17,276	$	5,857	$	14,791	$	2,758	$	640	$	633	$	6,732	$	763	$	232	$	1,031	$	454

(1) Net premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected future benefit payments.


	December 31, 2025
	Aflac Japan								Aflac U.S.
(In millions)	Cancer		Medical and Other Health		Life Insurance		Other		Accident		Disability		Critical Care		Hospital Indemnity		Dental/ Vision		Life Insurance		Other
Present value of expected future net premiums:
Balance at December 31, 2024	$	14,184	$	11,817	$	5,156	$	846	$	2,497	$	1,635	$	3,901	$	1,122	$	196	$	909	$	826
Beginning balance at original discount rate	14,008		11,845		5,084		864		2,687		1,726		4,340		1,221		209		976		824
Effect of changes in cash flow assumptions	(661)		136		(40)		5		18		(22)		(163)		(8)		(10)		(5)		386
Effect of actual variances from expected experience	(436)		(84)		(62)		(12)		21		20		(2)		16		(10)		(32)		146
Adjusted beginning of period balance	12,911		11,897		4,982		857		2,726		1,724		4,175		1,229		189		939		1,356
Issuances	1,114		253		405		9		295		341		488		211		50		246		571
Interest accrual	364		292		110		16		110		69		177		50		9		42		73
Net premiums collected (1)	(1,379)		(1,076)		(795)		(95)		(487)		(402)		(590)		(255)		(39)		(171)		(138)
Foreign currency translation	193		146		70		13		0		0		0		0		0		0		0
Other	(2)		(1)		0		0		(7)		(6)		(8)		(4)		(1)		(5)		(27)
Ending balance at original discount rate	13,201		11,511		4,772		800		2,637		1,726		4,242		1,231		208		1,051		1,835
Effect of changes in discount rate assumptions	(994)		(1,162)		(225)		(75)		(112)		(41)		(297)		(60)		(6)		(30)		133
Balance at December 31, 2025	$	12,207	$	10,349	$	4,547	$	725	$	2,525	$	1,685	$	3,945	$	1,171	$	202	$	1,021	$	1,968
Present value of expected future policy benefits:
Balance at December 31, 2024	$	40,781	$	20,606	$	24,265	$	4,225	$	3,127	$	2,330	$	10,701	$	1,897	$	441	$	1,847	$	1,288
Beginning balance at original discount rate	37,856		21,957		26,330		4,765		3,386		2,466		12,013		2,073		477		2,126		1,293
Effect of changes in cash flow assumptions	(1,130)		108		(101)		74		47		(46)		(219)		(4)		(15)		(17)		399
Effect of actual variances from expected experience	(483)		(102)		(61)		(21)		9		5		(15)		8		(13)		(53)		148
Adjusted beginning of period balance	36,243		21,963		26,168		4,818		3,442		2,425		11,779		2,077		449		2,056		1,840
Issuances	1,138		260		417		14		300		355		503		217		50		254		574
Interest accrual	1,299		564		569		91		138		99		515		87		20		87		97
Benefit payments	(2,723)		(1,044)		(1,753)		(218)		(532)		(478)		(985)		(310)		(61)		(109)		(207)
Foreign currency translation	481		236		315		53		0		0		0		0		0		0		0
Other	0		0		0		0		0		0		0		0		0		0		0
Ending balance at original discount rate	36,438		21,979		25,716		4,758		3,348		2,401		11,812		2,071		458		2,288		2,304
Effect of changes in discount rate assumptions	(1,451)		(4,287)		(4,822)		(1,087)		(164)		(65)		(967)		(116)		(20)		(212)		140
Balance at December 31, 2025	34,987		17,692		20,894		3,671		3,184		2,336		10,845		1,955		438		2,076		2,444
Net liability for future policy benefits	22,780		7,343		16,347		2,946		659		651		6,900		784		236		1,055		476
Less: reinsurance recoverable	4,406		1,062		0		0		0		0		0		0		0		25		11
Net liability for future policy benefits after reinsurance recoverable	$	18,374	$	6,281	$	16,347	$	2,946	$	659	$	651	$	6,900	$	784	$	236	$	1,030	$	465

(1) Net premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected future benefit payments.

Schedule of Weighted-Average Interest Rates and Liability Duration for Future Policy Benefits

The following tables present the weighted-average interest rates and weighted-average liability duration (calculated using the original discount rate) by reporting segment and disaggregated by product type.


	March 31, 2026
	Aflac Japan				Aflac U.S.
	Cancer	Medical and Other Health	Life Insurance	Other	Accident	Disability	Critical Care	Hospital Indemnity	Dental/ Vision	Life Insurance	Other
Weighted-average interest, original discount rate (1)	3.8 %	2.5 %	2.1 %	1.8 %	4.1 %	4.4 %	4.5 %	4.5 %	4.4 %	4.0 %	5.5 %
Weighted-average interest, current discount rate (1)	3.8 %	4.4 %	3.5 %	4.1 %	5.4 %	5.2 %	5.6 %	5.5 %	5.4 %	5.5 %	5.6 %
Weighted-average liability duration (years)	12.3	22.6	16.4	16.0	7.9	5.6	10.8	9.0	7.4	13.6	8.3

(1) The weighted-average interest rates are calculated using the reserve balances as the weights. No adjustments were made to observable market information.


	December 31, 2025
	Aflac Japan				Aflac U.S.
	Cancer	Medical and Other Health	Life Insurance	Other	Accident	Disability	Critical Care	Hospital Indemnity	Dental/ Vision	Life Insurance	Other
Weighted-average interest, original discount rate (1)	3.8 %	2.5 %	2.1 %	1.8 %	4.1 %	4.4 %	4.5 %	4.5 %	4.3 %	3.9 %	5.5 %
Weighted-average interest, current discount rate (1)	3.1 %	3.6 %	2.8 %	3.4 %	5.2 %	5.0 %	5.4 %	5.3 %	5.2 %	5.3 %	5.4 %
Weighted-average liability duration (years)	12.3	22.9	16.2	16.2	7.8	5.6	10.8	9.0	7.5	13.5	8.6

(1) The weighted-average interest rates are calculated using the reserve balances as the weights. No adjustments were made to observable market information.

Reconciliation of Future Policy Benefits

The following table presents a reconciliation of the disaggregated rollforwards above to the ending liability for future policy benefits presented in the consolidated balance sheets. The deferred profit liability for limited-payment contracts and the deferred reinsurance gain liability are presented together with the liability for future policy benefits in the consolidated balance sheets and have been included as reconciling items in the table below.


(In millions)	March 31, 2026			December 31, 2025
Balances included in future policy benefits rollforward:
Aflac Japan
Cancer		$	21,418		$	22,780
Medical and other health		6,851			7,343
Life insurance		15,107			16,347
Other		2,758			2,946
Aflac U.S.
Accident		640			659
Disability		633			651
Critical care		6,732			6,900
Hospital indemnity		763			784
Dental/vision		232			236
Life insurance		1,057			1,055
Other		474			476
Corporate and other		4,593			4,317
Deferred profit liability		2,061			2,066
Deferred reinsurance gain liability		895			757
Intercompany eliminations (1)		(4,695)			(4,997)
Total		$	59,519		$	62,320

(1) Elimination entry necessary due to the internal reinsurance transactions with Aflac Re and to recapture a portion of policy liabilities ceded externally as a result of the reinsurance retrocession transaction. See Note 8 of the Notes to the Consolidated Financial Statements in the 2025 Annual Report.

Summary of Net Earned Premiums Recognized

The following table summarizes the amount of net earned premiums recognized in the consolidated statements of earnings by reporting segment and disaggregated by product type.


	Three Months Ended March 31,
(In millions)		2026		2025
Net earned premiums:
Aflac Japan
Cancer		$	816	$	839
Medical and other health		495		529
Life insurance		298		316
Other		29		32
Aflac U.S.
Accident		305		311
Disability		374		352
Critical care		444		441
Hospital indemnity		183		184
Dental/vision		58		49
Life insurance		198		169
Other		63		49
Corporate and other		182		198
Reinsurance ceded		(135)		(88)
Total		$	3,310	$	3,381

Summary of Interest Expense Related to Insurance Contracts Recognized

The following table summarizes the amount of interest expense related to insurance contracts recognized in benefits and claims, excluding reserve remeasurement in the consolidated statements of earnings by reporting segment and disaggregated by product type.


	Three Months Ended March 31,
(In millions)		2026		2025
Interest expense:
Aflac Japan
Cancer		$	217	$	233
Medical and other health		66		66
Life insurance		108		114
Other		18		18
Aflac U.S.
Accident		7		7
Disability		7		7
Critical care		83		85
Hospital indemnity		10		9
Dental/vision		3		3
Life insurance		12		11
Other		6		6

Total		$	537	$	559

Summary of Undiscounted and Discounted Expected Future Gross Premiums and Expected Future Policy Benefits and Expenses

The following tables present the amount of expected future gross premiums and expected future policy benefits and expenses (undiscounted and discounted at the current period discount rate) by reporting segment and disaggregated by product type. These tables are presented gross of internal and external ceded reinsurance.

Future gross premiums represent the expected amount of future premiums to be received. For limited-payment policies, the premiums are collected over a shorter period than the policy term over which benefits are provided. As a result, once the policy reaches premium paid-up status, the future gross premiums can be significantly less than the future benefit payments. Further, benefits and expenses are generally greater in the later years of a policy. These are the primary factors that result in future gross premiums lower than future benefit and expense payments for certain lines of business of the Company.


	March 31, 2026						December 31, 2025
(In millions)	Gross Premiums			Benefits and Expenses			Gross Premiums			Benefits and Expenses
Undiscounted expected future gross premiums and expected future policy benefits and expenses:
Aflac Japan
Cancer		$	51,004		$	53,308		$	52,505		$	54,844
Medical and other health		31,455			33,991			32,757			35,043
Life insurance		10,468			36,171			10,781			37,340
Other		1,297			6,216			1,351			6,419
Aflac U.S.
Accident		8,545			4,638			8,560			4,660
Disability		5,720			3,055			5,697			3,033
Critical care		19,272			20,020			19,182			19,971
Hospital indemnity		4,812			3,052			4,757			3,027
Dental/vision		1,074			659			1,081			657
Life insurance		3,527			4,115			3,326			3,948
Other		4,191			4,786			3,477			4,105
Total		$	141,365		$	170,011		$	143,474		$	173,047


	March 31, 2026						December 31, 2025
(In millions)	Gross Premiums			Benefits and Expenses			Gross Premiums			Benefits and Expenses
Discounted expected future gross premiums and expected future policy benefits and expenses:
Aflac Japan
Cancer		$	34,767		$	32,936		$	36,796		$	34,987
Medical and other health		20,742			16,476			22,239			17,692
Life insurance		8,216			19,394			8,625			20,894
Other		953			3,435			1,018			3,671
Aflac U.S.
Accident		5,919			3,125			6,002			3,184
Disability		4,435			2,322			4,478			2,336
Critical care		11,865			10,690			11,988			10,845
Hospital indemnity		3,334			1,946			3,333			1,955
Dental/vision		737			434			755			438
Life insurance		2,469			2,118			2,358			2,076
Other		2,482			2,804			2,105			2,444
Total		$	95,919		$	95,680		$	99,697		$	100,522

Schedule of Changes in Other Policyholders' Funds

The following table presents the changes in other policyholders’ funds.


(In millions)	March 31, 2026		December 31, 2025
Other policyholders' funds:
Fixed annuities account balance, beginning of period (1)	$	5,152	$	5,221
Premiums received	24		97
Transfers from WAYS conversions	79		307
Surrenders and withdrawals	(19)		(64)
Benefit payments	(136)		(513)
Interest credited	12		49
Foreign currency translation and other	(107)		55
Fixed annuities account balance, end of period	5,005		5,152
Other deposit type reserves	418		293
Total	$	5,423	$	5,445

(1) Aflac Japan fixed annuities

Schedule of Other Policyholders' Funds by Guaranteed Crediting Rates

The following table presents other policyholders’ funds balances by range of guaranteed crediting rates.

March 31, 2026

December 31, 2025

(In millions)

Range of Guaranteed

Minimum Crediting

Rates (2)

At
Guaranteed
Minimum

Cash
Surrender
Value

Range of Guaranteed

Minimum Crediting

Rates (2)

At
Guaranteed
Minimum

Cash
Surrender
Value

Fixed annuities (1)

0.5% - 2.2%

$5,005

$4,939

0.5% - 2.2%

$5,152

$5,083

(1) Aflac Japan fixed annuities

(2) Weighted-average crediting rate of 1.5% at March 31, 2026 and December 31, 2025.